Black women have worse breast cancer mortality regardless of cancer subtype

Black women with breast cancer had significantly worse survival compared with other racial and ethnic groups across cancer subtypes, which suggests that the survival differences are not solely attributable to the fact that black women are more frequently diagnosed with less treatable breast cancer subtypes, according to data presented at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10.

"The results seem to indicate that although African-American women are more likely to be diagnosed with less treatable subtypes of compared with white women, it is not the only reason they have worse ," said Candyce Kroenke, M.P.H., Sc.D., research scientist at Kaiser Permanente Division of Research in Oakland, Calif.

Kroenke and colleagues examined the link between race and breast cancer survival in a prospective cohort of 1,688 enrolled in the Life After and Pathways study. The survivors had been treated for luminal A, luminal B, basal-like or HER2-enriched breast cancer.

The researchers obtained participants' self-reported race information from mailed questionnaires. They tested samples of the patients' tumors to determine their molecular subtype of cancer.

After 6.3 years of follow-up, 499 women had died, 268 of them from breast cancer. Consistent with previous data, were nearly two times more likely to have died from breast cancer compared with white women. In addition, black women were less likely to be diagnosed with either the luminal A or luminal B breast cancer subtypes compared with white women.

"African-Americans were more likely to have the hard-to-treat triple-negative breast cancer subtype and had a lower likelihood of having the luminal A subtype, which tends to be the most treatable subtype of breast cancer and has the best prognosis," Kroenke said.

However, the researchers found that among blacks appeared consistent across breast cancer subtypes. Compared with , black women were 2.3 times more likely to die from the luminal A breast cancer subtype, 2.6 times more likely to die from the luminal B subtype, 1.3 times more likely to die from the basal-like subtype and 2.4 times more likely to die from the HER2-enriched subtype.

"African-Americans with breast cancer appeared to have a poorer prognosis regardless of subtype," Kroenke said. "It seems from our data that the black–white breast cancer survival difference cannot be explained entirely by variable breast cancer subtype diagnosis."

add to favorites email to friend print save as pdf

Related Stories

Breast cancer etiology may vary by subtype

May 21, 2009

Women's reproductive and lifestyle characteristics can be linked to different invasive breast cancer subtypes. Data on 2544 breast cancer cases, presented in the open access journal Breast Cancer Research, suggests that t ...

Recommended for you

Gene test aids cancer profile

5 hours ago

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

How a common antacid could lead to cheaper anti-cancer drugs

22 hours ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.